KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Return on Equity: 2009-2025

Historic Return on Equity for Charles River Laboratories International (CRL) over the last 16 years, with Sep 2025 value amounting to -0.02%.

  • Charles River Laboratories International's Return on Equity fell 14.00% to -0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.02%, marking a year-over-year decrease of 14.00%. This contributed to the annual value of 0.01% for FY2024, which is 14.00% down from last year.
  • Per Charles River Laboratories International's latest filing, its Return on Equity stood at -0.02% for Q3 2025, which was down 18.91% from -0.02% recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Return on Equity high stood at 0.18% for Q2 2021, and its period low was -0.02% during Q3 2025.
  • For the 3-year period, Charles River Laboratories International's Return on Equity averaged around 0.08%, with its median value being 0.12% (2024).
  • Its Return on Equity has fluctuated over the past 5 years, first rose by 2bps in 2021, then decreased by 14bps in 2025.
  • Over the past 5 years, Charles River Laboratories International's Return on Equity (Quarterly) stood at 0.16% in 2021, then increased by 2bps to 0.18% in 2022, then declined by 4bps to 0.14% in 2023, then fell by 13bps to 0.01% in 2024, then decreased by 14bps to -0.02% in 2025.
  • Its Return on Equity was -0.02% in Q3 2025, compared to -0.02% in Q2 2025 and -0.01% in Q1 2025.